Navigation Links
Orexigen(R) Therapeutics Schedules March 9, 2010 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2009
Date:3/4/2010

code 19470590. The webcast can be accessed live on the investor relations section of the Orexigen web site at www.orexigen.com and will be archived for 14 days following the call.

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead investigational product, Contrave®, has completed Phase 3 clinical trials.  The Company's second product, Empatic™, has completed Phase 2 clinical development.  Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss, through combination therapeutic approaches.  Further information about the Company can be found at http://www.Orexigen.com.

SOURCE Orexigen Therapeutics, Inc.

Back to top

RELATED
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
2. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
3. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
4. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
5. Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference
6. Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
7. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
8. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
9. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
10. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
11. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Big Market Research presents a detailed analysis of the Hepatitis ... France , Germany , ... Japan . Current scientific views on the Hepatitis definition, ... volume and sales forecasts by country for HAV NAT, HBV NAT, ... Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: ...
(Date:5/5/2015)... 2015  Image Stream Medical, a leader in OR ... one of the largest group purchasing organizations, serving four ... terms of the three-year agreement, Image Stream,s portfolio of ... made available to MedAssets members beginning on July 1, ... Medical CEO Eddie Mitchell said, ...
(Date:5/5/2015)... 2015 Research and Markets ( ... "Clinical Laboratory,Molecular Diagnostics and Genomic Testing Services ... Asia Pacific Version" report to their offering. ... growing. Clinical laboratory testing is positioned to directly ... A range of dynamic trends are pushing market ...
Breaking Medicine Technology:2015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3Image Stream Medical Announces Agreement with MedAssets 2Asia Pacific Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Report 2015-2019 2
... Published in Journal ,Nutrition, WALTHAM, Mass., Sept. ... today in the journal Nutrition that a botanical,supplement ... that are associated with over-expression of inflammation,and risk ... few studies that recruited,study subjects who have different ...
... Sept. 25 Findings from an international,multicenter, randomized, ... in the treatment of moderate to severe,plaque psoriasis ... the 21st meeting,of the World Congress of Dermatology, ... 2007 in Buenos Aires, Argentina. The presentation, ...
Cached Medicine Technology:Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products 2Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products 3Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products 4Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products 5Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting 2
(Date:5/5/2015)... 2015 Leveraging the industry-leading technology found ... an experienced team of fertility specialists are committed to ... around the globe. , “We’re honored that Maternity Health ... a global leader in reproductive medicine. The clinic offers ... in the world who play an important role in ...
(Date:5/5/2015)... PA (PRWEB) May 05, 2015 The 2015 ... raised $110,000 to benefit their global research, outreach and patient ... silent auction, and awards ceremony that attracted hundreds of supporters. ... of the discovery of the hepatitis B virus (HBV) by ... Blumberg received the Nobel Prize in Medicine for his discovery ...
(Date:5/5/2015)... Viverae®, a health management and engagement ... multinational developer, manufacturer and marketer of innovative, life-enhancing ... oncology and surgical specialty products, as the recipient ... Award recognizes outstanding achievement in the design and ... client base. , Viverae reviewed the employee wellness ...
(Date:5/5/2015)... Sunny skies and cool temperatures made for ... 400 runners and walkers participated in Global Lyme Alliance’s (GLA) ... , The 5K and 10K runs and 1-and 3-mile ... to raise funds for tick-borne disease research. The “Lyme Walk ... recent merger of Lyme Research Alliance (LRA) and Tick-Borne ...
(Date:5/5/2015)... Skedans Systems a division ... the Skedans Sensor Collaboration Platform at AUVSI's Unmanned ... app developers, provides tooling to deliver real time information ... The Skedans Sensor Collaboration Platform is a single unified ... of Things, Web Real Time Communications (WebRTC), and commercial ...
Breaking Medicine News(10 mins):Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2
... High-coverage human papillomavirus (HPV) vaccinations among adolescents and young ... warts, cervical cell abnormalities, and diagnostic and therapeutic procedures, ... 5 in the Journal of the National Cancer ... of cervical, vulvar, and vaginal cancers. This study ...
... laws, online testing and Super Bowl plug , FRIDAY, ... concussions in youth sports are making headway on several fronts: ... will get big play Sunday at Super Bowl XLIV, and ... trainers and doctors determine when it,s safe for an athlete ...
... say , FRIDAY, Feb. 5 (HealthDay News) -- Minimally ... injuries in surgeons, suggests a new survey. , University ... percent of laparoscopic surgeons who took part in the ... "We face a pending epidemic of occupational injuries to ...
... , TROY, Mich. , Feb. 5 ... and web products and services company serving U.S. hospitals and ... to the newly formed position of vice president, Marketing, ... , "I am delighted to have Colleen join the CareTech ...
... Feb. 5 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX:HAE) announces that ... 2010 of the delay within which to make a proposal ... its creditors it filed on January 8, 2010 under ... intended to allow Haemacure to complete a call for tenders for ...
... at the Harvard School of Public Health (HSPH) shows that almost ... and levels of concern about getting sick with the virus continue ... will be another widespread outbreak of the H1N1 virus in the ... the population (43%) does say such an outbreak is "somewhat likely." ...
Cached Medicine News:Health News:News brief: HPV vaccines may reduce a wide range of genital diseases 2Health News:Concussion Awareness for Young Athletes Gets Big Play 2Health News:CareTech Solutions Names Colleen M. Hanley Vice President of Marketing, Communications and Government Affairs 2Health News:CareTech Solutions Names Colleen M. Hanley Vice President of Marketing, Communications and Government Affairs 3Health News:Nearly half of Americans believe H1N1 outbreak is over, poll finds 2Health News:Nearly half of Americans believe H1N1 outbreak is over, poll finds 3Health News:Nearly half of Americans believe H1N1 outbreak is over, poll finds 4Health News:Nearly half of Americans believe H1N1 outbreak is over, poll finds 5Health News:Nearly half of Americans believe H1N1 outbreak is over, poll finds 6
... I system consists of four basic components: sample ... metal clamping plate (see diagram). The sample well ... spots, dots, or slots (see below). All three ... an accessory plate in conjunction with a complete ...
... Bio-Dot SF (slot format) microfiltration units provide ... nucleic acid in solution onto nitrocellulose or ... accommodated by using interchangeable templates to form ... format Bio-Dot SF apparatus. Each is available ...
... and Bio-Dot SF (slot format) microfiltration units ... or nucleic acid in solution onto nitrocellulose ... be accommodated by using interchangeable templates to ... slot format Bio-Dot SF apparatus. Each is ...
... clear, APET plastic tray. Ideal for staining ... trays used for multipurposes. Pour spouts in ... marker or label may be used for ... on rockers or shakers for staining several ...
Medicine Products: